DIVISLABBSEDivis Laboratories LtdLowNeutral
Announced Thu, 14 May · 12:10 IST

Divis Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/05/2026 ,inter alia, to consider and approve audited standalone and consolidated ....

DIVISLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-0.9%1-day move
₹6820.00
prior close
₹6859.50
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.1-0.0+0.2+0.7-0.9+0.2+1.3+0.9+0.7-0.4-3.0-3.0+5.5
Up moveDown movePending
AI summary

Divis Laboratories has notified exchanges that a Board meeting is scheduled for May 23, 2026 to consider and approve the audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026. The Board will also consider recommending a dividend on equity shares for FY 2025-26. The trading window for dealing in company securities has been closed since April 01, 2026 and will remain closed until 48 hours after the results are declared (i.e., till May 25, 2026). This is a standard regulatory intimation under SEBI Listing Regulations and does not contain the actual financial results.

Likely market impact

This is a routine advance intimation and does not contain financial data or surprises. The actual results and dividend recommendation will be known after May 23, 2026, which could move the stock depending on whether they meet, beat, or miss market expectations.